US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

43.62

-1.5742-3.48%

Volume:3K

Turnover:109.44K

Market Cap:32.72M

PE:- -

High:43.76

Open:43.66

Low:43.62

Close:45.20

52wk High:45.20

52wk Low:31.44

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.16

T/O Rate:0.33%

Dividend:0.14

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

THOMSON REUTERS

Natera- Signatera Commercial Launch in Japan Expected in 1H 2027

THOMSON REUTERS

Ligand Buys Ryjunea Royalty, Milestone Interest from Sydnexis for $23 Million

Ligand Pharmaceuticals Incorporated - to Receive Tiered Royalty on Ryjunea Net Sales in Emea

THOMSON REUTERS

Ligand Pharmaceuticals Incorporated - Buys Rights to Royalty and Milestone Payments on Ryjunea in Emea

THOMSON REUTERS

Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million

THOMSON REUTERS

Adaptive Biotechnologies Price Target Raised to $34.00/Share from $25.00 by BTIG

Analysts Are Bullish on These Healthcare Stocks: Ligand Pharma (LGND), Disc Medicine (IRON)

Insight Molecular Diagnostics Revises Chronix Royalty Agreement Terms

China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund

Electra Therapeutics indicated to open at $20, IPO priced at $15

Natera Says Lung Cancer MRD Study Links Signatera Results to 3-Year Recurrence-Free Survival in 1,129 Patients

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Sells 1,195 Shares for $32,265

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

Natera Inc Stock (NTRA) Moved Up by 5.05% on Sep 17: Key Drivers Unveiled

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

Guardant Health on Track for Record High Close

Adaptive Biotechnologies reports update to NCCN guidelines for Multiple Myeloma

Adaptive Biotechnologies Announces Update to Nccn Guidelines® for Multiple Myeloma, Strengthening Mrd Testing Recommendations and Specifically Referencing Clonoseq®

THOMSON REUTERS

Alert Incorrectly Tagged to Adaptive Biotechnologies Withdrawn

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/HELX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":43.621,"timestamp":1791307651171,"preClose":45.1952,"halted":0,"volume":2503,"delay":0,"changeRate":-0.03483113250964699,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Trading","change":-1.5742,"latestTime":"10-06 13:35:36 EDT","open":43.66,"high":43.76,"low":43.621,"amount":109436.31618,"amplitude":0.003076,"askPrice":43.12,"askSize":600,"bidPrice":42.96,"bidSize":600,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791316800000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":45.1952,"sharesOutstanding":650000,"nav":43.859,"aum":32894030.1,"dividendRate":0.003313,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":43.79,"preClose":45.1952,"latestTime":"16:10 EDT","volume":7,"amount":313.556,"timestamp":1791231005654,"change":-1.4052,"changeRate":-0.031092,"amplitude":0},"volumeRatio":0.156718,"impliedVol":0.1225,"impliedVolPercentile":0.5139},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.156718,"shares":750000,"dividePrice":0.1445,"high":43.76,"amplitude":0.003076,"preClose":45.1952,"low":43.621,"week52Low":31.44,"pbRate":"--","week52High":45.1952,"institutionHeld":0,"latestPrice":43.621,"eps":0,"divideRate":0.003313,"volume":2503,"delay":0,"ttmEps":0,"open":43.66,"prevYearClose":36.3062,"prevWeekClose":43.79,"prevMonthClose":44.5641,"prevQuarterClose":44.5641,"fiveDayClose":44.4008,"twentyDayClose":41.6426,"sixtyDayClose":39.7282},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669600141","title":"Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669600141","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669600141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078405,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA93GLLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1064131342.USD","LU0963586101.USD","LU2264538146.SGD","LU2324357040.USD","NTRA","LU0345770308.USD","GNOM","LU0106261612.USD","LU0012050646.USD","LU0345770993.USD","LU2065170008.USD","LU0053671581.USD","LU2065171402.SGD","HELX","LU1988902786.USD","LU2065171311.SGD","LU2065731478.USD","BK4139","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141228","title":"Natera- Signatera Commercial Launch in Japan Expected in 1H 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141228?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078405,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA93GLLM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0963586101.USD","LU2065171311.SGD","LU2264538146.SGD","LU0106261612.USD","LU0012050646.USD","LU1064131342.USD","LU1988902786.USD","LU2065169927.USD","BK4139","LU0345770993.USD","NTRA","LU2324357040.USD","LU0053671581.USD","GNOM","LU0345770308.USD","LU2065170008.USD","LU2065731478.USD","LU2065171402.SGD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146936","title":"Ligand Buys Ryjunea Royalty, Milestone Interest from Sydnexis for $23 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146936","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146936?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:02","pubTimestamp":1790074938,"startTime":"0","endTime":"0","summary":"Ligand buys Ryjunea royalty, milestone interest from Sydnexis for $23 millionLigand Pharmaceuticals bought a 100% interest in Sydnexis payment rights tied to Santen’s Ryjunea for a USD 23 million upfr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL5zH3n5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","HELX","LU2210149790.SGD","SG9999014013.SGD","IE0009354923.USD","LU0314104364.USD","BK4112","LGND","IE00BN0W2V16.EUR","BK4007","NDAQ","BK4588","SG9999014005.SGD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4139","LU0566484027.USD","IE00BQXX3F31.USD","IE00B64PRP62.GBP","SG9999014039.USD","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669814659","title":"Ligand Pharmaceuticals Incorporated - to Receive Tiered Royalty on Ryjunea Net Sales in Emea","url":"https://stock-news.laohu8.com/highlight/detail?id=2669814659","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669814659?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:00","pubTimestamp":1790074801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABLLRPD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGND","BK4139","HELX","LU0566484027.USD","LU1559883803.SGD","IE0009354923.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146592","title":"Ligand Pharmaceuticals Incorporated - Buys Rights to Royalty and Milestone Payments on Ryjunea in Emea","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146592?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:00","pubTimestamp":1790074801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABLLRPD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","IE0009354923.USD","LU1559883803.SGD","HELX","LU0566484027.USD","LGND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146516","title":"Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146516","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146516?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:00","pubTimestamp":1790074801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABLLRPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGND","LU1559883803.SGD","BK4007","IE0009354923.USD","LU0566484027.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437251","title":"Adaptive Biotechnologies Price Target Raised to $34.00/Share from $25.00 by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437251","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437251?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:19","pubTimestamp":1790072340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADPT/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT","BK4121","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148615","title":"Analysts Are Bullish on These Healthcare Stocks: Ligand Pharma (LGND), Disc Medicine (IRON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669148615?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:30","pubTimestamp":1790069407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ligand Pharma (LGND), Disc Medicine (IRON) and Immun...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ligand-pharma-lgnd-disc-medicine-iron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ligand-pharma-lgnd-disc-medicine-iron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU1559883803.SGD","BK4585","LU0029874061.USD","LU0053671581.USD","HELX","HCSG","BK4137","XBI","BK4007","LU0566484027.USD","BK4581","IE0009354923.USD","LABU","BK4588","LGND","BK4139","XLV","IRON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669193923","title":"Insight Molecular Diagnostics Revises Chronix Royalty Agreement Terms","url":"https://stock-news.laohu8.com/highlight/detail?id=2669193923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669193923?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:59","pubTimestamp":1790024393,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics ( ($IMDX) ) has issued an announcement. Insight Molecular Diagnostics Inc. operates in the molecular diagnostics indu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/insight-molecular-diagnostics-revises-chronix-royalty-agreement-terms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/insight-molecular-diagnostics-revises-chronix-royalty-agreement-terms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","BMED","HELX","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126968451","title":"China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=1126968451","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126968451?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:34","pubTimestamp":1789979675,"startTime":"0","endTime":"0","summary":"China-Singapore Suzhou Industrial Park Development Group Co., Ltd. (601512.SH) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HART","MEDX","BK1574","LNGR","HELX","BK1100","AGNG","09996","GDOC","LGHT","601512","PTH","BK1583","159883","BK0273","WDNA","IEIH","RSPH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668892453","title":"Electra Therapeutics indicated to open at $20, IPO priced at $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2668892453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668892453?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:55","pubTimestamp":1789743321,"startTime":"0","endTime":"0","summary":"Electra Therapeutics (ETRA), a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/electra-therapeutics-indicated-to-open-at-20-ipo-priced-at-15-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/electra-therapeutics-indicated-to-open-at-20-ipo-priced-at-15-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FDIF","GNOM","BK4585","JDOC","MEDX","LFSC","GNMX","PBE","BK4588","ETRA","GDOC","FRHC","BMED","IBB","BK4127","REDS","IDNA","SYNB","IPOS","TMAT","XT","KCE","HTEC","WDNA","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668421699","title":"Natera Says Lung Cancer MRD Study Links Signatera Results to 3-Year Recurrence-Free Survival in 1,129 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2668421699","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668421699?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:01","pubTimestamp":1789725664,"startTime":"0","endTime":"0","summary":"Natera says lung cancer MRD study links Signatera results to 3-year recurrence-free survival in 1,129 patientsNatera disclosed clinical data already presented at the IASLC 2026 World Conference on Lun","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL4kcGf8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU2264538146.SGD","BK4139","LU0963586101.USD","LU1064131342.USD","LU2065169927.USD","LU1988902786.USD","GNOM","NTRA","LU2065171311.SGD","LU0053671581.USD","LU2065731478.USD","HELX","LU0345770308.USD","LU2065171402.SGD","LU0106261612.USD","LU2065170008.USD","LU0345770993.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990420","title":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Sells 1,195 Shares for $32,265","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990420","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990420?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:51","pubTimestamp":1789685462,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sells 1,195 shares for $32,265Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 1,195 common shares on Sep. 15","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDLw809m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Sells 1,195 Shares for $32,265","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","HELX","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668976309","title":"Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300","url":"https://stock-news.laohu8.com/highlight/detail?id=2668976309","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668976309?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:10","pubTimestamp":1789679402,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa sells 116 common shares for $20,300Guardant Health director Tariq Musa sold 116 common shares on Sep. 16, 2026 at USD 175.Directly held common stock fell to 11,449 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL5VHhJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","GDOC","FFOX","LFSC","LU0109394709.USD","LU0320765992.SGD","BK4585","BK4196","HELX","BK4551","PTH","GNMX","GH","BK4535","EKG","GNOM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994618","title":"Natera Inc Stock (NTRA) Moved Up by 5.05% on Sep 17: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994618","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994618?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:15","pubTimestamp":1789672525,"startTime":"0","endTime":"0","summary":"• Natera reported strong adoption for Signatera and positive Medicare reimbursement updates.\n• The company achieved robust top-line revenue growth with $2.31B annual revenue.\n• Analysts issued Buy ratings with an average price target of $342.35.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262173862-market-movers-ntra-20260917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","HELX","LU0053671581.USD","LU1988902786.USD","NTRA","LU2065170008.USD","BK4139","LU2065731478.USD","LU2264538146.SGD","LU2065169927.USD","LU0963586101.USD","LU0345770993.USD","LU1064131342.USD","LU0012050646.USD","LU0106261612.USD","LU2324357040.USD","LU2065171402.SGD","GNOM","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668995985","title":"US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2668995985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668995985?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:20","pubTimestamp":1789658440,"startTime":"0","endTime":"0","summary":"UPDATE 6-US Health Secretary Kennedy Jr. adds eight new members to key health committeeSept 17 (Reuters)-US Health Secretary Robert F. Kennedy Jr. on Thursday named eight new members to the advisory p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4N4591AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4551","FFOX","GDOC","BK4585","EKG","LFSC","BK4196","GH","HELX","LU0320765992.SGD","BK4588","GNMX","LU0889565916.HKD","PTH","GNOM","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668998049","title":"Guardant Health on Track for Record High Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2668998049","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668998049?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:16","pubTimestamp":1789654560,"startTime":"0","endTime":"0","summary":"Guardant Health, Inc.  is currently at $180.24, up $5.34 or 3.05%--Would be new all-time closing high --Would be the first new record closing high since Feb. 12, 2021, when it closed at $179.10--On pace for largest percent increase since Sept. 15, 2026, when it rose 4.65%--Currently up three of the past four days--Up 13.34% month-to-date--Up 76.46% year-to-date--Up 206.52% from 52 weeks ago , when it closed at $58.80--Would be a new 52-week closing high--Up 212.53% from its 52-week closing low of $57.67 on Sept. 24, 2025--Traded as high as $181.50; new all-time intraday high --Up 3.77% at today's intraday highAll data as of 10:14:03 AM ETSource: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Guardant Health on Track for Record High Close","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4196","LFSC","BK4585","GH","LU0889565916.HKD","LU0109394709.USD","HELX","GDOC","FFOX","BK4551","GNOM","GNMX","LU0320765992.SGD","BK4588","EKG","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668326962","title":"Adaptive Biotechnologies reports update to NCCN guidelines for Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2668326962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668326962?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:11","pubTimestamp":1789647087,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies (ADPT) highlighted updates to the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for Multi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adaptive-biotechnologies-reports-update-to-nccn-guidelines-for-multiple-myeloma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adaptive-biotechnologies-reports-update-to-nccn-guidelines-for-multiple-myeloma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HELX","ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668691964","title":"Adaptive Biotechnologies Announces Update to Nccn Guidelines® for Multiple Myeloma, Strengthening Mrd Testing Recommendations and Specifically Referencing Clonoseq®","url":"https://stock-news.laohu8.com/highlight/detail?id=2668691964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668691964?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:00","pubTimestamp":1789646404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA3LT1KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","HELX","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969754","title":"Alert Incorrectly Tagged to Adaptive Biotechnologies Withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969754","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969754?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:10","pubTimestamp":1789643456,"startTime":"0","endTime":"0","summary":"ADVISORY-Alert incorrectly tagged to Adaptive Biotechnologies withdrawnAn alert from agentic accounting platform Adaptive announcing a fundraise was inadvertently tagged to publicly listed Adaptive Bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUAC7NJCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT","HELX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}